3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Neoplasms
2
Venous Thrombosis
1
Venous Thromboembolism
1
Vascular Diseases
1
Urogenital Neoplasms
1
Thromboembolism
1
Pulmonary Embolism
1
Prostatic Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lymphoma
1
Lymphatic Diseases
1
Lung Neoplasms
1
Leukemia
1
Intestinal Neoplasms
1
Hemostatic Disorders
1
Digestive System Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Blood Specimen Collection
32
Surveys and Questionnaires
24
Radiotherapy
12
Gene Expression Profiling
12
Drug Therapy
12
Surgical Procedures, Operative
11
Bronchoscopy
10
Magnetic Resonance Spectroscopy
9
Immunotherapy
9
Immunohistochemistry
9
Tomography, X-Ray Computed
8
Specimen Handling
8
Observation
8
Amplified Fragment Length Polymorphism Analysis
8
Polymerase Chain Reaction
7
pembrolizumab
6
Psychiatric Rehabilitation
6
Interviews as Topic
6
Carboplatin
6
Thoracic Surgery, Video-Assisted
5
Reverse Transcriptase Polymerase Chain Reaction
5
Microarray Analysis
5
Liquid Biopsy
5
Chemoradiotherapy
5
Bevacizumab
5
durvalumab
4
Therapeutics
4
Paclitaxel
4
Nivolumab
4
Ipilimumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Lung Neoplasms
×
Tinzaparin
×
Clear all
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled